HUP0200431A2 - Eljárás a petefészek programozott, ellenőrzött stimulálására szolgáló gyógyszerkészítmény előállítására - Google Patents

Eljárás a petefészek programozott, ellenőrzött stimulálására szolgáló gyógyszerkészítmény előállítására

Info

Publication number
HUP0200431A2
HUP0200431A2 HU0200431A HUP0200431A HUP0200431A2 HU P0200431 A2 HUP0200431 A2 HU P0200431A2 HU 0200431 A HU0200431 A HU 0200431A HU P0200431 A HUP0200431 A HU P0200431A HU P0200431 A2 HUP0200431 A2 HU P0200431A2
Authority
HU
Hungary
Prior art keywords
programmed
pharmaceutical compositions
compositions useful
stimulation protocol
producing pharmaceutical
Prior art date
Application number
HU0200431A
Other languages
English (en)
Inventor
Jürgen Engel
Hilde Riethmüller-Winzen
Original Assignee
Zentaris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Ag filed Critical Zentaris Ag
Publication of HUP0200431A2 publication Critical patent/HUP0200431A2/hu
Publication of HUP0200431A3 publication Critical patent/HUP0200431A3/hu
Publication of HU229252B1 publication Critical patent/HU229252B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0200431A 1999-03-31 2000-03-21 Process for producing pharmaceutical compositions useful for a programmed, controlled ovarian stimulation protocol HU229252B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12724199P 1999-03-31 1999-03-31
US13163299P 1999-04-28 1999-04-28
PCT/EP2000/002466 WO2000059542A1 (en) 1999-03-31 2000-03-21 Method for a programmed controlled ovarian stimulation protocol

Publications (3)

Publication Number Publication Date
HUP0200431A2 true HUP0200431A2 (hu) 2002-07-29
HUP0200431A3 HUP0200431A3 (en) 2004-04-28
HU229252B1 HU229252B1 (en) 2013-10-28

Family

ID=26825471

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200431A HU229252B1 (en) 1999-03-31 2000-03-21 Process for producing pharmaceutical compositions useful for a programmed, controlled ovarian stimulation protocol

Country Status (28)

Country Link
US (1) US8173592B1 (hu)
EP (1) EP1165138B1 (hu)
JP (1) JP4616999B2 (hu)
KR (1) KR100679880B1 (hu)
CN (1) CN1346281B (hu)
AR (1) AR023249A1 (hu)
AT (1) ATE265862T1 (hu)
AU (1) AU768544B2 (hu)
BG (1) BG65270B1 (hu)
BR (1) BR0009477A (hu)
CA (1) CA2367214C (hu)
CO (1) CO4970741A1 (hu)
CZ (1) CZ299820B6 (hu)
DE (1) DE60010452T2 (hu)
DK (1) DK1165138T3 (hu)
ES (1) ES2219331T3 (hu)
HK (1) HK1044892B (hu)
HU (1) HU229252B1 (hu)
IL (2) IL145630A0 (hu)
MX (1) MXPA01009862A (hu)
NO (1) NO327210B1 (hu)
NZ (1) NZ514964A (hu)
PL (1) PL199569B1 (hu)
PT (1) PT1165138E (hu)
RU (1) RU2226395C2 (hu)
SK (1) SK287244B6 (hu)
TW (1) TWI241194B (hu)
WO (1) WO2000059542A1 (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0788799A3 (en) 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagonists in the treatment of fertility disorders
EA008098B1 (ru) * 2003-02-21 2007-02-27 Шеринг Акциенгезельшафт Стойкий к уф-излучению трансдермальный пластырь
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US8962013B2 (en) * 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
EP1719504A1 (de) * 2005-05-02 2006-11-08 Schering AG Festes transdermales therapeutisches System mit UV-Absorber
AU2006270749B2 (en) * 2005-07-22 2013-02-07 Takeda Pharmaceutical Company Limited Premature ovulation preventive agent
WO2014072350A1 (en) * 2012-11-09 2014-05-15 Iasomai Ab N-acetyl-l-cysteine for use in in vitro fertilization
WO2016044271A2 (en) 2014-09-15 2016-03-24 Children's Medical Center Corporation Methods and compositions to increase somatic cell nuclear transfer (scnt) efficiency by removing histone h3-lysine trimethylation
CN107405385A (zh) 2015-04-17 2017-11-28 辉凌公司 用于治疗不育的组合物
AU2017336338B2 (en) * 2016-09-30 2022-11-10 Sumitomo Pharma Switzerland Gmbh Methods of treating female infertility
RU2665967C1 (ru) * 2017-06-14 2018-09-05 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) Способ стимуляции роста фолликулов в программах экстракорпорального оплодотворения у пациенток с бесплодием различного генеза и "бедным ответом на стимуляцию"
CN107982520A (zh) * 2017-12-25 2018-05-04 上海交通大学医学院附属第九人民医院 外源性MPA与hMG在制备动物模型药物中的应用
CN110570952B (zh) * 2018-06-05 2022-04-12 北京大学第三医院 预测拮抗剂方案下受试者卵巢低反应概率的系统及指导促性腺激素起始用药剂量选择的系统
CN110491505B (zh) * 2019-08-22 2021-06-01 北京大学第三医院（北京大学第三临床医学院） 预测受试者卵巢刺激过程中获得的卵母细胞数量的系统
CN113456801A (zh) * 2021-08-05 2021-10-01 浙江大学医学院附属第四医院 人绒毛膜促性腺激素在制备早发性卵巢功能不全患者的助孕药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016259A (en) * 1974-07-26 1977-04-05 Research Corporation Contraceptive polypeptides
ATE65407T1 (de) * 1984-04-03 1991-08-15 Serono Lab Verfahren zur herbeifuehrung der ovulation.
HU221589B (hu) 1989-03-10 2002-11-28 Endorecherche Inc. Emlő- és méhrák kezelésére alkalmas kombinációs gyógyszerkészítmény és eljárás előállítására
US5470847A (en) * 1993-12-10 1995-11-28 Board Of Regents, The University Of Texas System Ovulation control by regulating nitric oxide levels with arginine derivatives
AU691952B2 (en) 1994-07-22 1998-05-28 Eastern Virginia Medical School Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
EP0788799A3 (en) * 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagonists in the treatment of fertility disorders
US5945128A (en) * 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
CA2200541C (en) 1997-01-22 2013-02-19 Philippe Bouchard Lhrh-antagonists in the treatment of fertility disorders
AU4325797A (en) * 1997-06-23 1999-01-04 Mcneil-Ppc, Inc. Acetaminophen and cisapride analgesics
EP1082129B1 (en) * 1998-04-23 2003-10-29 Zentaris AG Method for the treatment of fertility disorders

Also Published As

Publication number Publication date
AR023249A1 (es) 2002-09-04
EP1165138A1 (en) 2002-01-02
NO327210B1 (no) 2009-05-11
KR20010105401A (ko) 2001-11-28
WO2000059542A9 (en) 2001-11-22
ATE265862T1 (de) 2004-05-15
CZ299820B6 (cs) 2008-12-03
PL199569B1 (pl) 2008-10-31
KR100679880B1 (ko) 2007-02-07
MXPA01009862A (es) 2003-10-14
JP2002541122A (ja) 2002-12-03
NO20014736D0 (no) 2001-09-28
ES2219331T3 (es) 2004-12-01
US8173592B1 (en) 2012-05-08
TWI241194B (en) 2005-10-11
IL145630A (en) 2009-09-01
AU768544B2 (en) 2003-12-18
EP1165138B1 (en) 2004-05-06
BG106045A (en) 2002-05-31
AU4106900A (en) 2000-10-23
HUP0200431A3 (en) 2004-04-28
CN1346281B (zh) 2010-04-14
NO20014736L (no) 2001-11-26
SK287244B6 (sk) 2010-04-07
CA2367214A1 (en) 2000-10-12
BG65270B1 (bg) 2007-11-30
JP4616999B2 (ja) 2011-01-19
CO4970741A1 (es) 2000-11-07
CZ20013495A3 (cs) 2002-06-12
PT1165138E (pt) 2004-09-30
RU2226395C2 (ru) 2004-04-10
CA2367214C (en) 2008-07-29
WO2000059542A1 (en) 2000-10-12
DK1165138T3 (da) 2004-08-30
HK1044892B (zh) 2011-06-30
BR0009477A (pt) 2002-01-08
SK13842001A3 (sk) 2002-09-10
IL145630A0 (en) 2002-06-30
DE60010452T2 (de) 2005-04-14
HK1044892A1 (en) 2002-11-08
CN1346281A (zh) 2002-04-24
DE60010452D1 (de) 2004-06-09
HU229252B1 (en) 2013-10-28
PL351327A1 (en) 2003-04-07
NZ514964A (en) 2003-08-29

Similar Documents

Publication Publication Date Title
HUP0000748A3 (en) 4-phenyl-piridine derivatives, process for producing them and pharmaceutical compositions containing them
HK1050370A1 (en) Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives.
IL161955A0 (en) A process for preparing 5-dihydro-pyrazolo Ä3,4-cÜpyrid-2-one derivatives
ZA200109849B (en) Pharmaceutical dosage forms for controlled release producing at least a timed pulse.
HUP0200431A3 (en) Process for producing pharmaceutical compositions useful for a programmed, controlled ovarian stimulation protocol
SG90091A1 (en) Process for producing epsilon-caprolactam
HUP0002843A3 (en) New betha-carboline compounds, a process for their preparation and pharmaceutical compositions containing them
IL140079A0 (en) Process for producing bisphennol a
HUP0004884A3 (en) Process for preparing 1,4-dihydropyridine derivatives
HUP0105479A3 (en) Betha-alanine derivatives, process for producing them and pharmaceutical compositions containing them
GB2350611B (en) Process for producing a diarylamine
AU2003274518A8 (en) A process for the preparation of benzyl 2-oxo-4- (heteroaryl) dithio-alpha-isoprenyl-1- azetidineazetate derivatives
HUP0201916A2 (en) Ethanesulfonyl-piperidine derivatives, process for producing them and pharmaceutical compositions containing them
IL144264A0 (en) Process for producing quinolinecarbaldehyde
GB2363379B (en) Process for producing alpha-aminoketones
IL146810A0 (en) Process for preparing 10, 11-methanobenzosuberane derivatives
HUP0202057A3 (en) 3-phenyl-3,7-diazabicyclo[3.3.1]nonan compounds, process for producing them and pharmaceutical compositions containing them
IL166514A0 (en) A process for preparing hydroxyazapirone derivatives
HUP0004469A3 (en) Process for producing trifluormethyl-aniline derivatives
ZA200107974B (en) Method for a programmed controlled ovarian stimulation protocol.
AU5135600A (en) Process for producing piperidine
HUP0000208A3 (en) Process for producing secondary-alkoxy-1-alkene derivatives
AU5567500A (en) Process for producing a hairdye composition
HUP9901938A2 (en) New process for producing 17-betha-hydroxy-17-alpha-methyl-2-oxa-5-alpha-androstan-3-on, as well as intermediate thereof
HUP0204401A3 (en) Process for producing 2,6-dichlorophenol derivatives

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: ZENTARIS GMBH, DE

Free format text: FORMER OWNER(S): ZENTARIS AG, DE; ZENTARIS GMBH, DE

GB9A Succession in title

Owner name: ZENTARIS IVF GMBH, DE

Free format text: FORMER OWNER(S): ZENTARIS AG, DE; AETERNA ZENTARIS GMBH, DE; ZENTARIS GMBH, DE; ZENTARIS GMBH, DE

HC9A Change of name, address

Owner name: ZENTARIS IVF GMBH, DE

Free format text: FORMER OWNER(S): ZENTARIS AG, DE; AETERNA ZENTARIS GMBH, DE; ZENTARIS GMBH, DE; ZENTARIS GMBH, DE